The structure and function of drug pumps: An update

Trends in Microbiology

Volumn 11, Issue 1, 2003, Pages 21-29

  McKeegan, Kenneth S ^a   Borges Walmsley, M Ines ^a   Walmsley, Adrian R ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIPORTER; CYTOTOXIC AGENT; MEMBRANE PROTEIN; MSBA PROTEIN; PROTEIN ACRB; PROTEIN BTUCD; PROTON; UNCLASSIFIED DRUG;

CELL DIVISION; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG TRANSPORT; ESCHERICHIA COLI; INFECTION RESISTANCE; MEMBRANE TRANSPORT; MOLECULAR RECOGNITION; NODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIA; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI PROTEINS; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0037230598     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(02)00010-0     Document Type: Review

References (56)

1. Borges-Walmsley M.I., Walmsley A.R. The structure and function of drug pumps. Trends Microbiol. 9:2001;71-79.
2. Chang G., Roth C.B. Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science. 293:2001;1793-1800.
3. Locher K.P., et al. The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science. 296:2002;1091-1098.
4. Murakami S., et al. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature. 419:2002;587-593.
5. Watkins R.E., et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 292:2001;2329-2333.
6. Schumacher M.A., et al. Structural mechanisms of QacR induction and multidrug recognition. Science. 294:2001;2158-2163.
7. Gottesman M.M., et al. P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Dev. 6:1996;610-617.
8. Leslie E.M., et al. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology. 167:2001;3-23.
9. Legare D., et al. The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J. Biol. Chem. 276:2001;26301-26307.
10. van Veen H.W., et al. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl Acad. Sci. U. S. A. 93:1996;10668-10672.
11. Kaur P. Expression and characterization of DrrA and DrrB proteins of Streptomyces peucetius in Escherichia coli: DrrA is an ATP binding protein. J. Bacteriol. 179:1997;569-575.
12. Holland I.B., Blight M.A. ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J. Mol. Biol. 293:1999;381-399.
13. Kaur P., Russell J. Biochemical coupling between the DrrA and DrrB proteins of the doxorubicin efflux pump of Streptomyces peucetius. J. Biol. Chem. 273:1998;17933-17939.
14. Rosenberg M.F., et al. Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle. EMBO J. 20:2001;5615-5625.
15. Lee J.-Y., et al. Projection structure of P-glycoprotein by electron microscopy: evidence for a 'closed' conformation of the nucleotide binding domains. J. Biol. Chem. 277:2002;40125-40131.
16. Rosenberg M.F., et al. The structure of the multidrug resistance protein 1 (MRP1/ABCC1): crystallization and single-particle analysis. J. Biol. Chem. 276:2001;16076-16082.
17. Chami M., et al. Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis. J. Mol Biol. 315:2002;1075-1085.
18. Velarde G., et al. Three-dimensional structure of transporter associated with antigen processing (TAP) obtained by single particle image analysis. J. Biol. Chem. 276:2001;46054-46063.
19. Doerrler W.T., Raetz C.R. ATPase activity of the MsbA lipid flippase of Escherichia coli. J. Biol. Chem. 277:2002;36697-36705.
20. Qu Q., Sharom F.J. FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated. Biochemistry. 40:2001;1413-1422.
21. Urbatsch I.L., et al. Cysteines 431 and 1074 are responsible for inhibitory disulfide cross-linking between the two nucleotide-binding sites in human P-glycoprotein. J. Biol. Chem. 276:2001;26980-26987.
22. Sharom F.J., et al. Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools. Semin. Cell Dev. Biol. 12:2001;257-265.
23. Loo T.W., Clarke D.M. Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity. J. Biol. Chem. 270:1995;22957-22961.
24. Hung L.-W., et al. Crystal structure of the ATP-binding subunit of an ABC transporter. Nature. 396:1998;703-707.
25. Armstrong S., et al. Powering the ABC transporter: 2.5 crystallographic structure of the ABC domain of RBSA. Pediat. Pulmonol. 17:1998;91-92.
26. Diederichs K., et al. Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis. EMBO J. 19:2000;5951-5961.
27. Yuan Y.R., et al. The crystal structure of the MJ0796 ATP-binding cassette. Implications for the structural consequences of ATP hydrolysis in the active site of an ABC transporter. J. Biol. Chem. 276:2001;32313-32321.
28. Karpowich N., et al. Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. Structure. 9:2001;571-586.
29. Gaudet R., Wiley D.C. Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing. EMBO J. 20:2001;4964-4972.
30. Hopfner K.P., et al. Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase. Cell. 105:2001;473-485.
31. Obmolova G., et al. Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA. Nature. 407:2000;703-710.
32. Zhou T., et al. Structure of the ArsA ATPase: the catalytic subunit of a heavy metal resistance pump. EMBO J. 19:2000;4838-4845.
33. Fetsch E.E., Davidson A.L. Vanadate-catalyzed photocleavage of the signature motif of an ATP-binding cassette (ABC) transporter. Proc. Natl Acad. Sci. U. S. A. 99:2002;9685-9690.
34. Moody J.E., et al. Cooperative, ATP-dependent dimerization of the nucleotide binding cassettes during the catalytic cycle of ABC transporters. J. Biol. Chem. 277:2002;21111-21114.
35. Smith P.C., et al. ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol. Cell. 10:2002;139-149.
36. Senior A.E. Catalytic mechanism of P-glycoprotein. Acta Physiol. Scand. 163:1998;213-218.
37. van Veen H.W., et al. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J. 19:2000;2503-2514.
38. Sauna Z.E., Ambudkar S.V. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc. Natl Acad. Sci. U.S.A. 97:2000;2515-2520.
39. Zhou T., et al. Unisite and multisite catalysis in the ArsA ATPase. J. Biol. Chem. 277:2002;23815-23820.
40. Aleksandrov L., et al. The first nucleotide binding domain of cystic fibrosis transmembrane conductance regulator is a site of stable nucleotide interaction, whereas the second is a site of rapid turnover. J. Biol. Chem. 277:2002;15419-15425.
41. Nikaido H., Zgurskaya H.I. AcrAB and related multidrug efflux pumps of Escherichia coli. J. Mol. Microbiol. Biotechnol. 3:2001;215-218.
42. Poole K. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3:2001;255-264.
43. Koronakis V., et al. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature. 405:2000;914-919.
44. Wong K.K.Y., Hancock R.E.W. Evaluation of a structural model of Pseudomonas aeruginosa outer membrane protein OprM, an efflux component involved in intrinsic antibiotic resistance. J. Bacteriol. 183:2000;367-374.
45. Hirai T., et al. Three-dimensional structure of a bacterial oxalate transporter. Nat. Struct. Biol. 9:2002;597-600.
46. Orth P., et al. Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system. Nat. Struct. Biol. 7:2000;215-219.
47. Zheleznova E.E., et al. Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter. Cell. 96:1999;353-362.
48. Heldwein E.E., Brennan R.G. Crystal structure of the transcription activator BmrR bound to DNA and a drug. Nature. 409:2001;378-382.
49. Alekshun M.N., et al. The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 Å resolution. Nat. Struct. Biol. 8:2001;710-714.
50. Brooun A., et al. Purification and ligand binding of EmrR, a regulator of a multidrug transporter. J. Bacteriol. 181:1999;5131-5133.
51. Edgar R., Bibi E. A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA. EMBO J. 18:1999;822-832.
52. Lewinson O., Bibi E. Evidence for simultaneous binding of dissimilar substrates by the Escherichia coli multidrug transporter MdfA. Biochemistry. 40:2001;12612-12618.
53. Margolles A., et al. The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids. Biochemistry. 38:1999;16298-16306.
54. Mitchell B.A., et al. Bioenergetics of the staphylococcal multidrug export protein QacA. Identification of distinct binding sites for monovalent and divalent cations. J. Biol. Chem. 274:1999;3541-3548.
55. Dey S., et al. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl Acad. Sci. U. S. A. 94:1997;10594-10599.
56. Martin C., et al. Communication between multiple drug binding sites on P-glycoprotein. Mol. Pharmacol. 58:2000;624-632.